User Photo Cancer-News

Preview

Susanna Curtis, MD @YaleCancer @YaleMed Medical Marijuana Associated with Fewer Hospitalizations for Individuals Living with SCD
Susanna Curtis, MD @YaleCancer @YaleMed Medical Marijuana Associated with Fewer Hospitalizations for Individuals Living with SCD
Neal Shore, MD @AtlanticUrology @Myovant #prostatecancer ESCALATE Trial Potential Enhancement of Prostate Cancer Treatment Options: First Patient Randomized in Phase III Trial
Neal Shore, MD @AtlanticUrology @Myovant #prostatecancer ESCALATE Trial Potential Enhancement of Prostate Cancer Treatment Options: First Patient Randomized in Phase III Trial
Xiang Cheng Ph.D. and Feng Geng Ph.D. @OSUCCC_James #braincancer Blocking Fat Storage Might Offer New Way to Treat Most Lethal Form of Brain Cancer
Xiang Cheng Ph.D. and Feng Geng Ph.D. @OSUCCC_James #braincancer Blocking Fat Storage Might Offer New Way to Treat Most Lethal Form of Brain Cancer
S. Michelle Shiller, DO, AP/CP, MGP @PathGroupLabs @LUNGevity Pan-Cancer Consortium Moves to Clarify and Promote Consistent Use of Common Terms for Biomarker and Germline Genetic Testing
S. Michelle Shiller, DO, AP/CP, MGP @PathGroupLabs @LUNGevity Pan-Cancer Consortium Moves to Clarify and Promote Consistent Use of Common Terms for Biomarker and Germline Genetic Testing
Miguel Ferreira, MSc @globaldataplc #hodgkinslymphoma Hodgkin’s lymphoma market to suffer with Adcetris patent expiry but benefit from new competitive landscape, says GlobalData
Miguel Ferreira, MSc @globaldataplc #hodgkinslymphoma Hodgkin’s lymphoma market to suffer with Adcetris patent expiry but benefit from new competitive landscape, says GlobalData
Petros Grivas, MD, PhD @SeattleCCA #UrothelialCancer FDA Approves Avelumab (BAVENCIO) as First-Line Maintenance Treatment for Patients with Locally Advanced or Metastatic Urothelial Carci...
Petros Grivas, MD, PhD @SeattleCCA #UrothelialCancer FDA Approves Avelumab (BAVENCIO) as First-Line Maintenance Treatment for Patients with Locally Advanced or Metastatic Urothelial Carci...
3926 Views in the last 30 days

Preview

Phase 1/2 AUGMENT-101 Trial @sloan_kettering
Phase 1/2 AUGMENT-101 Trial @sloan_kettering
Importance of Paradigms for Precision Medicine @sloan_kettering
Importance of Paradigms for Precision Medicine @sloan_kettering
Precision Medicine in Epichaperome Cancer Therapy @sloan_kettering
Precision Medicine in Epichaperome Cancer Therapy @sloan_kettering
1341 Views in the last 30 days
User Photo kidneycancer

Preview

Role of Radiation in Kidney Cancer
Role of Radiation in Kidney Cancer
Treatment-Free Survival, With and Without Toxicity
Treatment-Free Survival, With and Without Toxicity
Phase 2 Study of Lenvatinib Plus Pembrolizumab for Disease Progression After PD-1/PD-L1
Phase 2 Study of Lenvatinib Plus Pembrolizumab for Disease Progression After PD-1/PD-L1
What's To Come in Modern Imaging Technology
What's To Come in Modern Imaging Technology
Modern Imaging Technology
Modern Imaging Technology
Management of Clinical Cases in Kidney Cancer
Management of Clinical Cases in Kidney Cancer
712 Views in the last 30 days
User Photo obr

Preview

Oral Therapies in the Treatment of Myeloid Malignancies @YaleCancer
Oral Therapies in the Treatment of Myeloid Malignancies @YaleCancer
RWE in Older Patients with Acute Myeloid Malignancies
RWE in Older Patients with Acute Myeloid Malignancies
Role of Venetoclax in Treatment of MDS @YaleCancer
Role of Venetoclax in Treatment of MDS @YaleCancer
PRIMO Study Investigating Duvelisib in PTCL
PRIMO Study Investigating Duvelisib in PTCL
Novel Approaches in Development for the Treatment of PTCL
Novel Approaches in Development for the Treatment of PTCL
Studies in PTCL
Studies in PTCL
694 Views in the last 30 days
User Photo Annual-Meeting

Preview

Eric Jonasch, MD @MDANdersonNews #ASCO20 #renalcellcarcinoma #vonhippellindau #VHL Phase II study of the oral HIF-2α inhibitor MK-6482
Eric Jonasch, MD @MDANdersonNews #ASCO20 #renalcellcarcinoma #vonhippellindau #VHL Phase II study of the oral HIF-2α inhibitor MK-6482
Robert Coleman, MD, FACOG, FACS @USOResearch #ASCO20 #SSC #PBC #ovariancancer A phase III randomized controlled trial of secondary surgical cytoreduction
Robert Coleman, MD, FACOG, FACS @USOResearch #ASCO20 #SSC #PBC #ovariancancer A phase III randomized controlled trial of secondary surgical cytoreduction
Erik A. Williams, MD @FoundationATCG #softtissuesarcoma CDKN2C-Null Leiomyosarcoma: A Novel, Genomically Distinct Class of TP53/RB1
Erik A. Williams, MD @FoundationATCG #softtissuesarcoma CDKN2C-Null Leiomyosarcoma: A Novel, Genomically Distinct Class of TP53/RB1
Paolo Ghia, MD, Ph.D. @MyUniSR #RRCLL #CLL ASCEND: Phase III, Randomized Trial of Acalabrutinib
Paolo Ghia, MD, Ph.D. @MyUniSR #RRCLL #CLL ASCEND: Phase III, Randomized Trial of Acalabrutinib
Stephen B. Edge MD, FACS, FASCO @RoswellPark #ASCO20 Going off pathway: Problem or good care?
Stephen B. Edge MD, FACS, FASCO @RoswellPark #ASCO20 Going off pathway: Problem or good care?
Melissa Ann Geller, MD @UMNews #ASCO20 #ovariancancer APOLLO: A phase I study of adaptive memory natural killer (NK) cells in recurrent ovarian cancer
Melissa Ann Geller, MD @UMNews #ASCO20 #ovariancancer APOLLO: A phase I study of adaptive memory natural killer (NK) cells in recurrent ovarian cancer
576 Views in the last 30 days
User Photo VJHemOnc

Preview

Accelerating clinical trials in transplantation
Accelerating clinical trials in transplantation
Whole genome sequencing opens door for targeted Waldenström’s therapy
Whole genome sequencing opens door for targeted Waldenström’s therapy
Updated POLLUX results for early relapsed myeloma patients
Updated POLLUX results for early relapsed myeloma patients
Targeting BCMA with bispecific antibodies in R/R myeloma
Targeting BCMA with bispecific antibodies in R/R myeloma
Monoclonal antibodies: current and future potential
Monoclonal antibodies: current and future potential
Plasma cell leukemia and extramedullary disease in multiple myeloma
Plasma cell leukemia and extramedullary disease in multiple myeloma
366 Views in the last 30 days
User Photo VJOncology

Preview

BOPA18__VJO_Rachel Elliott_01
BOPA18__VJO_Rachel Elliott_01
New models for patient care: advanced pharmacy practitioners
New models for patient care: advanced pharmacy practitioners
Patient symptom and experience trackers
Patient symptom and experience trackers
Update from the Scottish Cancer Medicines Outcome Programme
Update from the Scottish Cancer Medicines Outcome Programme
The switch to biosimilar rituximab at UCH: 12 months on
The switch to biosimilar rituximab at UCH: 12 months on
CPX-351: liposomal daunorubicin and cytarabine for treating high-risk AML
CPX-351: liposomal daunorubicin and cytarabine for treating high-risk AML
185 Views in the last 30 days
User Photo AACR

Preview

Ammar Chaudhry, MD @cityofhope @AACR #AACR20 #glioblastoma Randiomic prediction of survival in recurrent high-grade glioma patients
Ammar Chaudhry, MD @cityofhope @AACR #AACR20 #glioblastoma Randiomic prediction of survival in recurrent high-grade glioma patients
Shailja Shah, MD, Ph.D. @VUMC_Cancer Study gauges specific site gastric cancer risks among ethnic groups
Shailja Shah, MD, Ph.D. @VUMC_Cancer Study gauges specific site gastric cancer risks among ethnic groups
Michael Wang, MD @michaelwangmd @MDAndersonNews @KitePharma FDA Approves First Cell-Based Gene Therapy For Adult Patients with Relapsed or Refractory MCL
Michael Wang, MD @michaelwangmd @MDAndersonNews @KitePharma FDA Approves First Cell-Based Gene Therapy For Adult Patients with Relapsed or Refractory MCL
David R. Gandara, MD @MDAndersonNews @GuardantHealth Now FDA approved, the Guardant360 CDx delivers critical genomic information to oncologists from a simple blood draw
David R. Gandara, MD @MDAndersonNews @GuardantHealth Now FDA approved, the Guardant360 CDx delivers critical genomic information to oncologists from a simple blood draw
Minesh P Mehta MD, FASTRO @BaptistHealthSF High- vs Low-Dose Radiation for Adult Low-Grade Glioma
Minesh P Mehta MD, FASTRO @BaptistHealthSF High- vs Low-Dose Radiation for Adult Low-Grade Glioma
Kazuhiko Matsuoka, PhD @MedUni_Wien Osteosarcoma (OS) is the most common form of aggressive bone cancer. A MedUni Vienna study, led by geneticist Erwin Wagner, has uncovered new insights ...
Kazuhiko Matsuoka, PhD @MedUni_Wien Osteosarcoma (OS) is the most common form of aggressive bone cancer. A MedUni Vienna study, led by geneticist Erwin Wagner, has uncovered new insights ...
179 Views in the last 30 days

Preview

@OncEd Presents Dr. Barb Melosky - Best of Lung Cancer - Best of Annual Meeting 2015 Vancouver
@OncEd Presents Dr. Barb Melosky - Best of Lung Cancer - Best of Annual Meeting 2015 Vancouver
@OncEd Presents Dr. Winson Cheung - Best of Health Services / Survivorship - Best of Annual Meeting 2015 Vancouver
@OncEd Presents Dr. Winson Cheung - Best of Health Services / Survivorship - Best of Annual Meeting 2015 Vancouver
@OncEd Presents Dr. Scott North - Best of Prostate - Best of Annual Meeting 2015 Vancouver
@OncEd Presents Dr. Scott North - Best of Prostate - Best of Annual Meeting 2015 Vancouver
@OncEd Presents Dr. Christian Kollmannsberger - Best of Non-Prostate - best of Annual Meeting 2015 Vancouver
@OncEd Presents Dr. Christian Kollmannsberger - Best of Non-Prostate - best of Annual Meeting 2015 Vancouver
@OncEd Presents Dr. Stephen Chia - Best of Breast Cancer - Best of Annual Meeting 2015 Vancouver
@OncEd Presents Dr. Stephen Chia - Best of Breast Cancer - Best of Annual Meeting 2015 Vancouver
@OncEd Presents Dr. Michael Smylie - Best of Melanoma - Best of Annual Meeting 2015 Vancouver
@OncEd Presents Dr. Michael Smylie - Best of Melanoma - Best of Annual Meeting 2015 Vancouver
166 Views in the last 30 days
User Photo HMP CME

Preview

COVID-19 & Hematologic Malignancies: Episode 7 - Infectious Disease Update
COVID-19 & Hematologic Malignancies: Episode 7 - Infectious Disease Update
COVID-19 & Hematologic Malignancies: Episode 6 - Myeloid Malignancies Update
COVID-19 & Hematologic Malignancies: Episode 6 - Myeloid Malignancies Update
COVID-19 & Hematologic Malignancies: Episode 5 - Patient Experience Update
COVID-19 & Hematologic Malignancies: Episode 5 - Patient Experience Update
COVID-19 & Hematologic Malignancies: Episode 4 - Effective Management & Patient Experience
COVID-19 & Hematologic Malignancies: Episode 4 - Effective Management & Patient Experience
COVID-19 & Hematologic Malignancies: Episode 3 - Myeloma Update
COVID-19 & Hematologic Malignancies: Episode 3 - Myeloma Update
COVID-19 & Hematologic Malignancies: Episode 2 - Lymphoma Update
COVID-19 & Hematologic Malignancies: Episode 2 - Lymphoma Update
165 Views in the last 30 days